CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: Initial experience

Radiology

Volumn 244, Issue 2, 2007, Pages 486-493

  Bellomi, Massimo ^a,b   Petralia, Giuseppe ^a,b   Sonzogni, Angelica ^b   Zampino, Maria Giulia ^b   Rocca, Andrea ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; IOPROMIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DRUG RESPONSE; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; MALE; MONITORING; PERMEABILITY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RANK SUM TEST; RECTUM; RECTUM CARCINOMA; WILCOXON SIGNED RANKS TEST;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; RECTUM; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34447498780     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2442061189     Document Type: Article

References (32)

1. Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31 (8):845-853.
2. Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control final report of intergroup 0114. J Clin Oncol 2002;20: (7)1744-1750.
3. O'Connell MJ. Current status of adjuvant therapy for colorectal cancer. Oncology (Williston Park) 2004;18(6):751-755.
4. Zhu AX, Willett CG. Combined modality treatment for rectal cancer. Semin Oncol 2005;32(1):103-112.
5. Hobday TJ. An overview of approaches to adjuvant therapy for colorectal cancer in the United Stales. Clin Colorectal Cancer 2005; 5(suppl 1):S11-S18.
6. Takebayashi Y, Aklyama S, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor hi human colorectal carcinoma. Cancer 1996;78(2):226-231.
7. Li C, Gardy R, Seon BK, et. al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 2003;88(9):1424-1431.
8. Cascinu S, Graziano F, Catalano V, et al. An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer: relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer 2002;86(5):744-749.
9. Theodoropoulos GF., Lazaris AC, Theodoropoulos VE, et al. Hypoxia, angiogenesis and opoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 2006;21 (3):248-257.
10. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: mi3 crovessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94(12);883-893.
11. Blankenberg FG, Eckelman WC, Strauss HW, et al. Role of radionuclide imaging in trials of antiangiogenic therapy. Acad Radiol 2000;7(10):851-867.
12. Brasch RC, Li KC, Husband JE, et al. In vivo monitoring of tumour angiogenesis with MR imaging. Acad Radiol 2000;7(10):812-823.
13. Harvey C, Dooher A, Morgan J, Blomley M, Dawson P. Imaging of tumour therapy responses by dynamic CT. Eur J Radiol 1999; 30(3):221-226.
14. Miles KA, Charnsangavej C, Lee FT, Fishman EK, Horton K, Lee TY. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7(10):840-850.
15. Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DA. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr 1999;23(4):540-547.
16. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours. 6th ed. New York, NY: Wiley, 2002.
17. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing Web site. http://www.R- project.org. Accessed June 15, 2006.
18. Li ZP, Meng QF, Sun CH, et al. Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation. World J Gastroenterol 2005;11(9):1287-1291.
19. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147(1):9-19.
20. Vermeulen PB, Libura M, Libura J, et al. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat 1997;42(2):165-172.
21. Hansen S, Grabau DA, Rose C, Bak M, Sorensen FB. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998;78(12):1563-1573.
22. Sabani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005;234(3): 785-792.
23. Goh V, Halligan S, Hugill JA, Gartner L, Bartram CI. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 2005;29(1):59-03.
24. Chan I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance hnaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24(4):668-674.
25. de Vries A, Griebel J, Kremser C, et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 2000;217(2):385-391.
26. George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88(12):1628-1636.
27. Mayr NA, Yuh WT, Arnholt JC, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12(6): 1027-1033.
28. Hermans R, Meijerink M, Van den Bogaert W, Bijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57(5):1351-1356.
29. Hermans B, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol 1999; 53(2):105-111.
30. Miles KA. Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76(spec no 1):S36-S42.
31. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging a meta-analysis. Radiology 2004; 232(3):773-783.
32. Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patienls with resectable rectal cancer. Int J Badiat Oncol Biol Phys 2005;62(3):761-768.